Another blow to Merck: Their potential blockbuster diabetes drug is showing some cardiac side effects. “”I expected the advisory panel to turn the drug down. When they didn’t, I was really surprised. And so I now had a potential public health catastrophe in the waiting.”
Related posts:
- Accomplia/rimonabant: Denied
- Januvia and Stevens-Johnson
- When drug side effects scare patients away from treatment
- Movies and Big Pharma
- Ketek is thisclose from being pulled
- Would you take a prescription drug for longer eyelashes?
- Nurses as the latest drug reps
KevinMD.com on Facebook
{ 1 comment }
God bless Merck. And the lawyers. I have now shorted this company for several thousand dollars profit, and they didn’t do diddly wrong. God Bless America. I hope their earnings Rock on Monday so it goes up and I can short some more.
Comments on this entry are closed.